Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Spectrum files sNDA with FDA for Fusilev in colorectal cancer

Nov. 3, 2008

Novel antisense oligonucleotide safe in preliminary data from phase I advanced cancer study

Nov. 3, 2008

New radiotherapeutic shows promising results in murine and primate melanoma models

Nov. 3, 2008

TRC-105 tolerated, active in ongoing phase I cancer study

Nov. 3, 2008

Recent patents impart new oncolytic drugs

Nov. 3, 2008

Eupatilin induces apoptosis in colon cancer cell line

Nov. 3, 2008

FDA accepts for priority review ImClone and Bristol-Myers' sBLA for Erbitux

Oct. 31, 2008

Telik reports top-line results from Assist-5 trial in ovarian cancer

Oct. 31, 2008

Infinity expands phase II study of IPI-504 in advanced non-small cell lung cancer

Oct. 31, 2008

SuperGen reports on development of JAK2 inhibitor SGI-1252

Oct. 31, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...